For people whose tinnitus comes with hearing loss, hearing aids often make it less noticeable and less bothersome, though the randomised evidence is thinner than their popularity suggests and the benefit varies from person to person.
Hearing aids are built to make sound louder and clearer, not to treat tinnitus. And yet for a large share of people whose tinnitus is linked to hearing loss — which, per the article on tinnitus and hearing loss, is most people with tinnitus — hearing aids are frequently the most effective single thing they try.
Why amplification helps tinnitus
The leading explanation for tinnitus is that the brain "turns up" its internal sensitivity in a frequency range where it's receiving a weaker signal from damaged hair cells, and that overcompensation is what gets perceived as tinnitus. Hearing aids restore audible input across that frequency range. With the missing signal partly restored, the auditory system has less reason to keep compensating — and for many wearers, tinnitus becomes noticeably less prominent, particularly during the day when there's speech and environmental sound for the aids to amplify.
There's a second, more straightforward mechanism too: hearing aids raise the general level of ambient sound reaching the ear, which increases the background "noise floor" tinnitus has to compete against — similar in effect to sound therapy, just delivered through a device already correcting hearing loss at the same time.
What to expect, realistically
Hearing aids don't eliminate tinnitus for everyone, and results vary based on the degree of hearing loss, how well the aids are fitted, and how closely the tinnitus pitch matches the frequencies where hearing loss is present. What's commonly reported is a reduction in how bothersome tinnitus is — less an "off switch" and more a turned-down, easier-to-ignore version, especially during waking hours when the aids are in.
What the trial data shows
A large multicenter European study — part of the UNITI research initiative, involving five study sites — followed 60 participants with chronic tinnitus and mild-to-moderate hearing loss through a 12-week hearing-aid-only treatment arm, professionally fitted and verified. Both tinnitus-related distress (measured on standard handicap and functional-impact scales) and subjective tinnitus loudness improved significantly over the treatment period. The same research program is also investigating which specific factors — tinnitus pitch, degree of hearing loss, how many hours a day the aids are worn, and fitting accuracy — best predict who benefits most, since response isn't uniform across everyone who tries amplification.
A separate retrospective study focusing specifically on "ski-slope" hearing loss — a steep pattern of high-frequency loss, common in noise-induced cases — found hearing aid amplification produced a clinically meaningful reduction in tinnitus handicap scores, using an 11-point drop on the standard Tinnitus Handicap Inventory as the threshold for a real, noticeable improvement rather than statistical noise. That choice has since been corroborated from a different direction: a 2025 multi-centre study estimating the smallest change patients notice by anchoring to their own ratings of improvement arrived at 11 points on the THI as well.
The widest view comes from a 2026 umbrella review that gathered 44 systematic reviews with meta-analysis across seven kinds of tinnitus treatment. It grouped hearing aids with CBT, tinnitus retraining therapy and sound or music therapy as the approaches that consistently improved tinnitus outcomes, while neuromodulation and acupuncture showed modest or inconsistent benefits.
None of this means hearing aids work identically for everyone — the same body of research is explicitly focused on figuring out who responds best, precisely because response varies. But the overall pattern is consistent: amplification helps tinnitus-related distress for a meaningful share of people with hearing loss, on the standardised outcome measures researchers use to evaluate any tinnitus treatment.
What Cochrane found, and why it sits oddly beside clinical practice
Hearing aids are among the most widely recommended things for tinnitus with hearing loss. The Cochrane review of that practice, published in 2014, found one randomised controlled trial, with 91 participants.
That is the whole randomised evidence base it could identify. The included trial was judged at low risk of bias for randomisation and outcome reporting, unclear elsewhere. It compared hearing aids against sound generators and found no difference between them on the Tinnitus Handicap Inventory (mean difference −0.90, 95% CI −7.92 to 6.12 on a 100-point scale), on moderate-quality evidence. No adverse events were reported.
The conclusion is worth quoting for its precision: the current evidence base for hearing aid prescription for tinnitus is limited, and there is currently no evidence to support or refute their use as a more routine intervention for tinnitus.
Three things keep that from being the end of the story, and they are why this article does not read as a negative:
- The review is from 2014. The 2026 umbrella review now lists hearing aids among the approaches that consistently improve tinnitus outcomes, and the 461-patient UNITI trial, which randomised people to CBT, hearing aids, app-based counselling, app-based sound therapy or pairs of them, found CBT and hearing aids alone had large before-and-after effect sizes. The trial had no untreated group, so those effects are measured against each arm's own starting point.
- Cochrane was asking a narrow question — hearing aids as a tinnitus treatment. Most people fitted with them have hearing loss worth treating on its own terms (it is also a recognised risk factor for dementia), and the tinnitus benefit arrives alongside a benefit nobody disputes.
- "No evidence to support or refute" is a statement about trials, not about patients. It describes a gap in the literature rather than a failure in the clinic.
What it should change is the expectation you walk in with: hearing aids for tinnitus rest on a thinner randomised base than their popularity suggests, and the stronger modern support comes from pooled syntheses rather than from a definitive trial.
Getting fitted specifically with tinnitus in mind
A standard hearing aid fitting focuses on speech clarity. If tinnitus relief is a specific goal, it's worth telling the audiologist directly — a few things change the approach:
- A verified fitting — real-ear or probe-microphone measurements that check the aids deliver the amplification your hearing loss calls for, which the American Tinnitus Association counts as part of what makes hearing aids well fitted
- Open or thin-tube fittings where appropriate, which can feel less "plugged" and reduce the occlusion effect (your own voice sounding boomy), which some wearers find increases perceived tinnitus if not addressed
- Combination devices, which layer a mild built-in sound generator on top of amplification — worth asking about if amplification alone doesn't provide enough relief
Changing the amplification at your tinnitus pitch does not appear to add anything. A 2026 multicentre trial randomised 108 adults to conventional, objectively verified amplification, to extra gain at the tinnitus pitch, or to a "notch" that removed gain there. Tinnitus distress fell in all three groups with no difference between them, and conventional amplification gave the most speech benefit — the same trial notched sound therapy discusses.
Even mild hearing loss is worth evaluating
A common misconception is that hearing aids are only for significant, obvious hearing loss. Mild or high-frequency-only loss — the kind that doesn't affect everyday conversation much — is common in people with tinnitus and easy to miss without formal testing. If you have tinnitus and haven't had a full audiogram, that's the logical first step before assuming hearing aids wouldn't help; how to read your audiogram explains what the chart shows.
Cost and access
In the US, cost is a real barrier. In the 2025 MarkeTrak survey of nearly 5,000 adults with hearing difficulty, the median reported cost was $1,560 per prescription hearing aid and $150 per over-the-counter aid, and most prescription owners had a pair. Original Medicare does not cover hearing aids or the exams to fit them, though some Medicare Advantage plans offer hearing benefits. In the UK, the NHS provides hearing aids free, on long-term loan, after a GP referral.
Over-the-counter hearing aids, available without a prescription for adults with perceived mild-to-moderate hearing loss, are the lower-cost entry point, and since 2024 they have included software that turns some earbuds into a hearing aid. The American Tinnitus Association says OTC aids may not be the best option for someone bothered by tinnitus: a prescription aid can be fitted to your audiogram and verified with real-ear measurements rather than relying on your own adjustments, and most prescription aids have tinnitus programmes that OTC devices currently lack.
Where the professional guidelines land
The American Academy of Otolaryngology–Head and Neck Surgery's clinical practice guideline on tinnitus recommends a hearing aid evaluation for patients with persistent, bothersome tinnitus and documented hearing loss. The 2024 VA/DoD guideline reaches the same place in its own terms: it suggests hearing aids for tinnitus management in adults with hearing loss (weak for), the same grade as its other positive recommendations, since none in that guideline is strong.
Note the condition attached to both: hearing loss. That is the argument for getting a full audiogram before deciding amplification is not for you, since mild or high-frequency-only loss is easy to miss without formal testing and is common in people with tinnitus.